298 related articles for article (PubMed ID: 32509254)
1. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
[TBL] [Abstract][Full Text] [Related]
2. Fungal Endophthalmitis in a Case of Rhino-Orbito-Cerebral Mucormycosis: Successfully Treated With Amphotericin B Colloidal Dispersion.
Zhao Y; Tian W; Yang J; Li X; Lu H; Yu N; Zhang P; Liu C; Chen P; Lei G; Liu Y
Front Microbiol; 2022; 13():910419. PubMed ID: 35783387
[TBL] [Abstract][Full Text] [Related]
3. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
[TBL] [Abstract][Full Text] [Related]
4. Rhino-Orbital Cerebral Mucormycosis in a Healthy Female Child: Case Report.
Yusuf AA; Ibrahim IG; Hirsi IM; Adali A; Hassan YY; Yasar MZ; Abdullahi IM; Hassan MS
Int Med Case Rep J; 2024; 17():241-246. PubMed ID: 38559497
[TBL] [Abstract][Full Text] [Related]
5. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
6. Survival after rhino-orbital-cerebral mucormycosis in an immunocompetent patient.
Fairley C; Sullivan TJ; Bartley P; Allworth T; Lewandowski R
Ophthalmology; 2000 Mar; 107(3):555-8. PubMed ID: 10711895
[TBL] [Abstract][Full Text] [Related]
7. Rhino-Orbital Cerebral Mucormycosis: A Fatal Evolution.
Benlamkaddem S; Zdaik G; Doughmi D; Bennis A; Chraibi F; Berdai MA; Abdellaoui M; Benatiya Andaloussi I; Harandou M
Cureus; 2023 Apr; 15(4):e37837. PubMed ID: 37214071
[TBL] [Abstract][Full Text] [Related]
8. Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study.
Cag Y; Erdem H; Gunduz M; Komur S; Ankarali H; Ural S; Tasbakan M; Tattevin P; Tombak A; Ozturk-Engin D; Tartar AS; Batirel A; Tekin R; Duygu F; Caskurlu H; Kurtaran B; Durdu B; Haciseyitoglu D; Rello J;
Eur J Intern Med; 2022 Jun; 100():56-61. PubMed ID: 35304041
[TBL] [Abstract][Full Text] [Related]
9. First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus.
Diwakar J; Samaddar A; Konar SK; Bhat MD; Manuel E; Hb V; Bn N; Parveen A; Hajira SN; Srinivas D; S N
J Mycol Med; 2021 Dec; 31(4):101203. PubMed ID: 34517273
[TBL] [Abstract][Full Text] [Related]
10. Rhino-Orbito-Cerebral Mucormycosis: A Challenging Case.
El Hakkouni A; Harrar S; Hachimi A; Mezouari M; Moutaj R
Cureus; 2023 Sep; 15(9):e44768. PubMed ID: 37809164
[TBL] [Abstract][Full Text] [Related]
11. Transcutaneous retrobulbar injection of amphotericin B in rhino-orbital-cerebral mucormycosis: a review.
Nair AG; Dave TV
Orbit; 2022 Jun; 41(3):275-286. PubMed ID: 34720026
[TBL] [Abstract][Full Text] [Related]
12. Rhino-orbito-cerebral mucormycosis: five cases.
Toumi A; Larbi Ammari F; Loussaief C; Hadhri R; Ben Brahim H; Harrathi K; Ben Romdhane F; Koubaa J; Chakroun M
Med Mal Infect; 2012 Dec; 42(12):591-8. PubMed ID: 23116703
[TBL] [Abstract][Full Text] [Related]
13. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
[TBL] [Abstract][Full Text] [Related]
14. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.
Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z
J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873
[TBL] [Abstract][Full Text] [Related]
15. Survival of a Rhino-Orbital-Cerebral Mucormycosis Patient after Localized Combination Liposomal Amphotericin B Medications: A Case Report.
Zhou Y
Case Rep Ophthalmol; 2024; 15(1):122-128. PubMed ID: 38322311
[TBL] [Abstract][Full Text] [Related]
16. Refractory rhino-orbito-cerebral mucormycosis treated with intraconal amphotericin B.
Guimarães JA; Moura FC
Arq Bras Oftalmol; 2022; 85(1):77-81. PubMed ID: 34468552
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of a case with rhino-orbital-cerebral mucormycosis by the combination of neurosurgical intervention and the sequential use of amphotericin B and posaconazole.
Yoon YK; Kim MJ; Chung YG; Shin IY
J Korean Neurosurg Soc; 2010 Jan; 47(1):74-7. PubMed ID: 20157385
[TBL] [Abstract][Full Text] [Related]
18. Rhino-orbital and rhino-orbito-cerebral mucormycosis.
Talmi YP; Goldschmied-Reouven A; Bakon M; Barshack I; Wolf M; Horowitz Z; Berkowicz M; Keller N; Kronenberg J
Otolaryngol Head Neck Surg; 2002 Jul; 127(1):22-31. PubMed ID: 12161726
[TBL] [Abstract][Full Text] [Related]
19. Breaking the Mold: A Review of Mucormycosis and Current Pharmacological Treatment Options.
Riley TT; Muzny CA; Swiatlo E; Legendre DP
Ann Pharmacother; 2016 Sep; 50(9):747-57. PubMed ID: 27307416
[TBL] [Abstract][Full Text] [Related]
20. A case of COVID-19-associated mucormycosis due to Lichtheimia ramosa.
Aboutalebian S; Erami M; Momen-Heravi M; Charsizadeh A; Hezaveh SJH; Matini AH; Ahsaniarani AH; Fakhrehi M; Mirhendi H
J Clin Lab Anal; 2023 Apr; 37(8):e24895. PubMed ID: 37183276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
